Amanote Research
Register
Sign In
Letter:CYP3A4/5genotype Status and Outcome of Vonoprazan-containingHelicobacter Pylorieradication Therapy in Japan
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13959
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
March 3, 2017
Authors
M. Sugimoto
H. Ban
D. Hira
T. Kamiya
T. Otsuka
O. Inatomi
S. Bamba
T. Terada
A. Andoh
Publisher
Wiley
Related search
H. pyloriEradication Therapy
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Marked Improvement in Refractory TTP Directly afterH. pyloriEradication Therapy
Case Reports in Hematology
Effect of Bacterial and Host Factors onHelicobacter Pylorieradication Therapy
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
H pyloriEradication and GERD
Canadian Journal of Gastroenterology
Vonoprazan-Based Therapy for Helicobacter Pylori Eradication: Experience and Clinical Evidence
Therapeutic Advances in Gastroenterology
Gastroenterology
Vonoprazan and Helicobacter Pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
Frontiers in Pharmacology
Pharmacology
Vonoprazan Versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-Effectiveness Analysis in Japan
Internal Medicine
Internal Medicine
Medicine
Present Status of Cardiology in Japan
Japanese Heart Journal
Historical Status of Meat Hygiene in Japan
Journal of the Japan Veterinary Medical Association
